GoldenGolden
Gemmus Pharma

Gemmus Pharma

A biotechnology company developing therapeutics for influenza and other infectious diseases

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

June 28, 2012
Gemmus Pharma raises a $1,800,000 series A round from BlueTree Allied Angels, Tech Coast Angels, The Angels and Wilmington Investor Network.

Funding rounds

People

Name
Role
LinkedIn

Ashley John Mullen

Investor

Carol Sands

Investor

Jonathan Gottfried

Investor

Michael Cain

Investor

Michael Cain

Investor

Sergio Gurrieri

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.